A detailed history of Kelly Lawrence W & Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 1,751 shares of AMGN stock, worth $465,678. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,751
Previous 1,826 4.11%
Holding current value
$465,678
Previous $570,000 1.05%
% of portfolio
0.13%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $23,203 - $25,303
-75 Reduced 4.11%
1,751 $564,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $19,284 - $22,803
-90 Reduced 4.7%
1,826 $405,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $65,044 - $82,646
-284 Reduced 12.91%
1,916 $503,000
Q3 2022

Nov 15, 2022

BUY
$224.46 - $253.15 $15,712 - $17,720
70 Added 3.29%
2,200 $496,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $184,186 - $203,758
-840 Reduced 28.28%
2,130 $515,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $59,664 - $68,280
-300 Reduced 9.17%
2,970 $668,000
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $231,452 - $269,719
1,043 Added 46.83%
3,270 $813,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $340,798 - $405,830
-1,575 Reduced 41.43%
2,227 $512,000
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $7,912 - $9,709
40 Added 1.06%
3,802 $897,000
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $303,458 - $354,233
-1,701 Reduced 31.14%
3,762 $733,000
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $55,587 - $62,666
300 Added 5.81%
5,463 $1.13 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $49,815 - $55,953
-300 Reduced 5.49%
5,163 $953,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $5,082 - $5,940
-30 Reduced 0.55%
5,463 $931,000
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $24,474 - $27,345
145 Added 2.71%
5,493 $955,000
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $894,666 - $1.02 Million
5,348
5,348 $997,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $142B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kelly Lawrence W & Associates Inc Portfolio

Follow Kelly Lawrence W & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.